Clinical utility of a newly developed microfluidic device for detecting circulating tumor cells in the blood of patients with pancreatico-biliary malignancies.

Naoki KonnoRei SuzukiTadayuki TakagiMitsuru SugimotoHiroyuki AsamaYuki SatoHiroki IrieTakuto HikichiHiromasa Ohira

Published in: Journal of hepato-biliary-pancreatic sciences (2020)

A newly developed microfluidic device could diagnose PB cancers by detecting CTCs. This trial was registered with the UMIN Clinical Trials Registry, no. UMIN000029808.

Keyphrases

circulating tumor cells
clinical trial
phase ii
phase iii
circulating tumor
study protocol
heavy metals
double blind
aqueous solution